The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,000.00
Bid: 1,975.00
Ask: 2,000.00
Change: 50.00 (2.56%)
Spread: 25.00 (1.266%)
Open: 1,955.00
High: 2,000.00
Low: 1,955.00
Prev. Close: 1,950.00
SUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

11 Aug 2009 07:00

RNS Number : 2015X
S & U PLC
11 August 2009
 



11 August 2009

S & U PLC ("S&U" or "the Company")

Trading update

Notice of Results

S&U, Britain's foremost niche home credit and motor finance provider, today announces a trading update for the six months to 31 July. The Company is pleased to announce that it is currently trading in line with market expectations and intends issuing its Interim results on 24 September 2009. 

HOME CREDIT

Current trading and profitability within our home credit division is very satisfactory and is encouraging for the full year outlook.

A more cautious sales and underwriting environment in the last six months has nevertheless seen a steady increase in customer numbers on shorter-term loan agreements and therefore more flexible book debt. This has been reflected in an improvement in collections quality and impairment against last year. Tight expense and overhead control has seen this represented in improved profitability; returning customer confidence should therefore see further profit advances in the second half of this financial year.

MOTOR FINANCE

Advantage Finance, our motor finance business which comprises just over 30% of Group revenue, continues to trade well and to exceed budget. Whilst applications continue to grow, a strict and prudent underwriting policy has seen revenue fall slightly by 4%, but overall collections are slightly ahead on stable book debt. Advantage continues to broaden its product range into the non-prime market and has seen significant improvements in debt quality as a result.

Although early redemptions are still lower than a year ago, borrowings are significantly lower too, thus allowing headroom for expansion in both its traditional sub-prime and newer non-prime markets.

FUNDING AND CAPITAL

In uncertain times, S&U's treasury and funding position is strong and continuing to strengthen. Gearing and borrowings are both less than last year, the latter by more than £4 m. Our medium term finance and overdraft facilities give us the potential for organic growth and careful acquisitions, particularly in the home credit sector.

OUTLOOK

As predicted S&U's trading has remained strong and the Company has strengthened its balance sheet, despite a particularly volatile and uncertain time in the economic cycle, Current trends suggest further progress in the second half, and a business performance which reflects the robust nature of our business model in the challenging economic environment.

Commenting, Mr Anthony Coombs, S&U Chairman, said:

"Trading is in line in the first half and the outlook for the full year remains positive".

For further information please contact:

S&U plc www.suplc.co.uk 

Anthony Coombs, Chairman 0121 705 7777 

 

Charles Stanley Securities 

Mark Taylor / Freddy Crossley 020 7149 6000 

 

Smithfield 

Reg Hoare / Rebecca Whitehead 020 7360 4900 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBLGDIRUBGGCG
Date   Source Headline
3rd May 20245:49 pmRNSDirector/PDMR and PCA Shareholding
3rd May 20242:00 pmRNSAnnual Report and Accounts
1st May 20244:19 pmRNSDirector/PDMR and PCA Shareholding
9th Apr 20247:00 amRNSPreliminary Unaudited FY Results to 31 Jan 24
25th Mar 20247:00 amRNSResults Presentations for Analysts and Investors
9th Feb 20247:00 amRNSTrading Statement and Notice of Results
1st Feb 20242:30 pmRNSNotice of Trading Update
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTrading Statement to 11 December 2023
31st Oct 20232:29 pmRNSDirector/PDMR and PCA Shareholding
5th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20237:00 amRNSInterim Results for the 6 months to 31 July 2023
4th Sep 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSTrading Update and Notice of Results
25th Jul 202311:34 amRNSDirector/PDMR Shareholding
17th Jul 20233:34 pmRNSDirector/PDMR Shareholding
26th May 20234:38 pmRNSDirector/PDMR Shareholding
25th May 202312:43 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Statement and Trading Update
25th Apr 20232:00 pmRNSAnnual Report and Accounts
25th Apr 202311:48 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSMello Investor Presentation
6th Apr 20234:08 pmRNSAnnouncement of Annual Report and Accounts
28th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Mar 20237:00 amRNSPreliminary Results
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSResults Presentations for Analysts and Investors
14th Feb 20232:00 pmRNSAppointment of Executive Director
9th Feb 20237:00 amRNSTrading Statement and Notice of Results
8th Dec 20227:00 amRNSTrading Statement
27th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSResults Presentations for Analysts and Investors
18th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20227:00 amRNSTrading Update and Notice of Results
3rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
8th Jul 20225:06 pmRNSDirector/PDMR and PCA Shareholding
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202212:33 pmRNSResult of AGM
26th May 20227:00 amRNSAGM Statement and Trading Update
23rd May 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
18th May 202211:30 amRNSOptions, Director/PDMR Shareholding, Voting Rights
13th May 20224:33 pmRNSDirector/PDMR Shareholding
5th May 20221:53 pmRNSDirector/PDMR Shareholding, Options, Voting Rights
26th Apr 20222:00 pmRNSAnnual Report and Accounts
4th Apr 20227:00 amEQSEdison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow
4th Apr 20227:00 amRNSAnnual Report and Accounts
29th Mar 20227:00 amRNSPreliminary Results
9th Mar 20227:00 amRNSResults Presentations for Analysts and Investors
10th Feb 20227:00 amRNSTrading Statement and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.